Every Exelixis employee is united in an ambitious cause: to launch innovative medicines that give patients, and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. After operating in the challenging biotech sector for 25 years, we have a proven track record of resiliency in the face of adversity. The success of our lead product has provided a solid commercial foundation allowing us to reinvigorate our research efforts and grow our team in areas such as Drug Discovery, Clinical Development and Commercial. As we expand our global partnerships and further reinvest in R&D to help us discover the next breakthrough for difficult-to-treat cancers, we’re seeking to add talented, dedicated employees to power our mission. Cancer is our cause. Make it yours, too. SUMMARY/JOB PURPOSE: As a member of the Biotherapeutics group, the incumbent will play a key role in supporting the group’s discovery and preclinical development efforts by possessing skills and experience in recombinant antibody and bispecific antibody production and purification/characterization. The incumbent will be responsible for delivering high performing and high-quality mammalian cell lines that enable early-phase biologics manufacturing for further development as potential therapeutic candidates or as ADCs. The ideal candidate will design and test vector constructs, engineer host cells, conduct transfection, selection and clone generation campaign in CHO cells, and apply a deep theoretical understanding of recombinant protein expression to guide the improvement of titer in stable cell lines.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal
Education Level
Ph.D. or professional degree